ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,442Medicare Part D Prescriptions Filled, Including Refills

Rank: 307 out of 1107

$494K Total Retail Price of All Prescriptions

Rank: 385 out of 1107

487 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 8,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 567 449 1 3
LISINOPRIL 370 272 2 2
RANITIDINE HCL 349 278 3 21
SIMVASTATIN 308 242 4 5
FUROSEMIDE 303 251 5 7
OMEPRAZOLE 294 226 6 4
HYDROCODONE-ACETAMINOPHEN 253 171 S3 7 1
GABAPENTIN 237 160 8 9
HYDROCHLOROTHIAZIDE 231 204 9 11
METFORMIN HCL 229 181 10 8
TRAMADOL HCL 204 163 11 26
WARFARIN SODIUM 200 161 12 15
POTASSIUM CHLORIDE 190 168 13 14
METOPROLOL SUCCINATE 188 170 14 16
NEXIUM 179 127 15 18
CITALOPRAM HBR 157 124 16 17
AMLODIPINE BESYLATE 155 141 17 6
CLOPIDOGREL 155 122 17 28
ATORVASTATIN CALCIUM 152 114 19 13
PLAVIX 129 101 20 39
CIPROFLOXACIN HCL 121 96 21 59
DIOVAN 114 96 22 51
GEMFIBROZIL 101 64 23 107
METOPROLOL TARTRATE 96 80 24 10
CARVEDILOL 95 78 25 27
GLIPIZIDE 88 67 26 64
ALENDRONATE SODIUM 84 64 27 41
CYCLOBENZAPRINE HCL 82 56 R 28 56
FLUTICASONE PROPIONATE 82 43 28 38
PROAIR HFA 73 31 30 37
AZITHROMYCIN 71 46 31 35
CRESTOR 70 56 32 23
MECLIZINE HCL 67 49 33 114
CYMBALTA 66 43 34 50
TAMSULOSIN HCL 66 58 34 30
ATENOLOL 66 53 34 19
PHENYTOIN SODIUM EXTENDED 64 36 37 147
DILTIAZEM 24HR CD 63 44 38 126
DIGOXIN 63 52 38 52
ZOLPIDEM TARTRATE 62 57 40 22
PROMETHAZINE HCL 61 39 R 41 44
LYRICA 59 39 42 83
AMITRIPTYLINE HCL 56 42 R 43 48
DONEPEZIL HCL 56 51 43 32
PREDNISONE 55 37 45 40
LOVASTATIN 55 27 45 55
POLYETHYLENE GLYCOL 3350 53 44 47 46
LIPITOR 53 38 47 109
PREMARIN 52 35 R 49 149
ISOSORBIDE MONONITRATE ER 51 40 50 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.